Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 122
10
Diseases
18
Unique genes
0.310
Avg. similarity score
Glucose-6-phosphate dehydrogenase deficiency
Most-connected disease (9 links)
Disease
Searched: IKBKG-related immunodeficiency with or without ectodermal dysplasia
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
IKBKG-related immunodeficiency with or without ectodermal dysplasia
Glucose-6-phosphate dehydrogenase deficiency
Anhidrotic ectodermal dysplasia with immunodeficiency, osteopetrosis, and lymphedema
Autoinflammatory disease, systemic, x-linked
Bloch sulzberger syndrome
G6PD deficiency
anemia, nonspherocytic hemolytic, due to G6PD deficiency
Granulomatous disease
incontinentia pigmenti
Peritonitis
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Glucose-6-phosphate dehydrogenase deficiency | 9 | 9 | 5 |
| Anhidrotic ectodermal dysplasia with immunodeficiency, osteopetrosis, and lymphedema | 8 | 8 | 2 |
| Autoinflammatory disease, systemic, x-linked | 8 | 8 | 2 |
| Bloch sulzberger syndrome | 7 | 7 | 2 |
| G6PD deficiency | 6 | 6 | 1 |
| anemia, nonspherocytic hemolytic, due to G6PD deficiency | 6 | 6 | 1 |
| Granulomatous disease | 5 | 5 | 9 |
| IKBKG-related immunodeficiency with or without ectodermal dysplasia | 5 | 5 | 1 |
| incontinentia pigmenti | 5 | 5 | 1 |
| Peritonitis | 1 | 1 | 7 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| G6PD | 7 / 10 | anemia, nonspherocytic hemolytic, due to G6PD deficiency, Anhidrotic ectodermal dysplasia with immunodeficiency, osteopetrosis, and lymphedema, Autoinflammatory disease, systemic, x-linked, Bloch sulzberger syndrome and 3 more |
| IKBKG | 6 / 10 | Anhidrotic ectodermal dysplasia with immunodeficiency, osteopetrosis, and lymphedema, Autoinflammatory disease, systemic, x-linked, Bloch sulzberger syndrome, Glucose-6-phosphate dehydrogenase deficiency and 2 more |
| IFNG | 3 / 10 | Glucose-6-phosphate dehydrogenase deficiency, Granulomatous disease, Peritonitis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cross-presentation of particulate exogenous antigens (phagosomes) | Reactome | 5 / 8 | 417× | 2.30e-13 | 5.04e-11 ✓ sig. |
| Leishmaniasis | KEGG | 7 / 78 | 59.9× | 1.11e-11 | 1.85e-9 ✓ sig. |
| RHO GTPases Activate NADPH Oxidases | Reactome | 5 / 24 | 139× | 1.72e-10 | 2.24e-8 ✓ sig. |
| Lipid and atherosclerosis | KEGG | 8 / 216 | 24.7× | 3.61e-10 | 4.28e-8 ✓ sig. |
| ROS and RNS production in phagocytes | Reactome | 5 / 34 | 98.1× | 1.12e-9 | 1.17e-7 ✓ sig. |
| Detoxification of Reactive Oxygen Species | Reactome | 5 / 34 | 98.1× | 1.12e-9 | 1.17e-7 ✓ sig. |
| Prion disease | KEGG | 8 / 275 | 19.4× | 2.45e-9 | 2.36e-7 ✓ sig. |
| Diabetic cardiomyopathy | KEGG | 7 / 205 | 22.8× | 1.03e-8 | 8.48e-7 ✓ sig. |
| VEGFA-VEGFR2 Pathway | Reactome | 5 / 62 | 53.8× | 2.53e-8 | 1.87e-6 ✓ sig. |
| Osteoclast differentiation | KEGG | 6 / 142 | 28.2× | 4.06e-8 | 2.85e-6 ✓ sig. |
| Neutrophil extracellular trap formation | KEGG | 6 / 192 | 20.9× | 2.44e-7 | 1.37e-5 ✓ sig. |
| Leukocyte transendothelial migration | KEGG | 5 / 116 | 28.8× | 5.97e-7 | 2.98e-5 ✓ sig. |
| Fluid shear stress and atherosclerosis | KEGG | 5 / 141 | 23.7× | 1.57e-6 | 6.90e-5 ✓ sig. |
| Phagosome | KEGG | 5 / 155 | 21.5× | 2.51e-6 | 1.03e-4 ✓ sig. |
| IL-17 signaling pathway | KEGG | 4 / 94 | 28.4× | 9.90e-6 | 3.22e-4 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| respiratory burst | GO:0045730 | 5 / 15 | 346× | 1.35e-12 | 5.99e-10 ✓ sig. |
| superoxide anion generation | GO:0042554 | 5 / 26 | 200× | 2.93e-11 | 9.75e-9 ✓ sig. |
| superoxide metabolic process | GO:0006801 | 4 / 22 | 189× | 4.36e-9 | 8.14e-7 ✓ sig. |
| hydrogen peroxide biosynthetic process | GO:0050665 | 3 / 11 | 283× | 1.23e-7 | 1.43e-5 ✓ sig. |
| innate immune response | GO:0045087 | 7 / 605 | 12.0× | 8.40e-7 | 7.18e-5 ✓ sig. |
| inflammatory response | GO:0006954 | 6 / 467 | 13.3× | 3.39e-6 | 2.22e-4 ✓ sig. |
| positive regulation of tumor necrosis factor production | GO:0032760 | 4 / 113 | 36.7× | 3.63e-6 | 2.34e-4 ✓ sig. |
| cellular response to L-glutamine | GO:1904845 | 2 / 4 | 519× | 5.25e-6 | 3.15e-4 ✓ sig. |
| positive regulation of receptor signaling pathway via JAK-STAT | GO:0046427 | 3 / 40 | 77.9× | 7.25e-6 | 4.08e-4 ✓ sig. |
| positive regulation of chemokine production | GO:0032722 | 3 / 49 | 63.6× | 1.34e-5 | 6.63e-4 ✓ sig. |
| response to activity | GO:0014823 | 3 / 52 | 59.9× | 1.61e-5 | 7.63e-4 ✓ sig. |
| cell surface receptor signaling pathway via JAK-STAT | GO:0007259 | 3 / 67 | 46.5× | 3.46e-5 | 1.37e-3 ✓ sig. |
| positive regulation of endothelial cell proliferation | GO:0001938 | 3 / 69 | 45.1× | 3.78e-5 | 1.46e-3 ✓ sig. |
| response to aldosterone | GO:1904044 | 2 / 10 | 208× | 3.93e-5 | 1.50e-3 ✓ sig. |
| positive regulation of MHC class II biosynthetic process | GO:0045348 | 2 / 15 | 138× | 9.13e-5 | 2.83e-3 ✓ sig. |